Revenue continues to grow strongly

Rua Bioscience Limited (“RUA”) is pleased to report continued month-on-month growth in sales revenue, as seen in our latest figures below (unaudited). With our products now available in three key markets - Aotearoa NZ, Australia and Germany - Rua is establishing a strong national and international presence. Apr24 - $6,000 May24 - $16,000 Jun24 - $23,000 Jul24 - $24,000 Aug24 - $82,000 Sep24 - $122,000 Oct24 - $128,000 Looking ahead, we are launching products in the UK within the next month, a move that we anticipate will further accelerate our strong growth trajectory. And we will also have new products in Aotearoa New Zealand and Germany before the end of this year. Our current revenue trajectory along with new product offerings in key markets give us confidence in our business plan. We are forecasting revenue over $3mill by the end of FY25. ENDS     The person who authorised this announcement: Paul Naske Chief Executive Officer paul.naske@ruabio.com +64 21 445154